Yes, some major previously unreported work here. The New York University transplant research has obviously gone well judging by the number of drugs in that category. We also see explicitly what is included on the Biofrontera side (irrespective of their other agreements which were confusing in this context). This is starting to look very good indeed.
News 
Market Data 
Discover 
